OpenAlex
PricingAboutJobs
Log inGet started
Work

HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2

HTML

Year: 2021
Type: article
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2021.10.003
Authors: Cassandra S.L. Ho, Alicia I. Tüns, Hans-Ulrich Schildhaus, Marcel Wiesweg, Barbara M. Grüner, Balazs Hegedus, Martin Schuler, Alexander Schramm, Sebastian Oeck
Institutions: Essen University Hospital, Stiftung Universitätsmedizin Essen, Deutsches Konsortium für Translationale Krebsforschung, Ruhrlandklinik, University of Duisburg-Essen
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: KRAS G12C, sotorasib, HER2, SHP2, drug resistance, lung cancer, MAPK signaling, KRAS inhibitors, combination therapy
SDG: Good health and well-being

Open Access status: closed

Funders: Deutsche Forschungsgemeinschaft, Daimler und Benz Stiftung, Deutsche Krebshilfe, Deutschen Konsortium für Translationale Krebsforschung
Awards: G617271991, G8935860984
OpenAlex ID: W3208053409
FWCI: 4.913
Cites: 18
Cited by: 52
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security